Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Carol Giltner Gallagher is a businessperson who has been the head of 5 different companies. Currently, Dr. Gallagher is Executive Chairman of Trex Bio, Inc. and Venture Partner at NEA Management Co. LLC. Dr. Gallagher is also on the board of 13 other companies.

In the past she was Independent Director at AnaptysBio, Inc., Chairman for eFFECTOR Therapeutics, Inc., Vice President-Sales & Marketing at Amgen, Inc. and Vice President-Product Planning at CancerVax Corp. (a subsidiary of Amgen, Inc.), Vice President-Sales & Marketing for Eli Lilly & Co., Director-Global Marketing Planning at Pfizer Inc. and Vice President-Sales & Marketing for Agouron Pharmaceuticals LLC (a subsidiary of Pfizer Inc.), Senior Director-Oncology Marketing at Biogen, Inc. and Rituxan Development Team Leader at IDEC Pharmaceuticals Corp. (a subsidiary of Biogen, Inc.), President & Chief Executive Officer at Metastatix, Inc., President & Chief Executive Officer for Calistoga Pharmaceuticals, Inc., SVP-Corporate Development & Commercial Affairs at Anadys Pharmaceuticals, Inc. and Venture Partner at Frazier Management LLC.

She received an undergraduate degree and a doctorate from the University of Kentucky College of Pharmacy.


Current positions of Carol Giltner Gallagher 
NameTitle Since
Certara, Inc.
(Software)
Independent Director 2021
Turning Point Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2019
Atara Biotherapeutics, Inc.
(Biotechnology & Medical Research)
Lead Independent Director 2013
Frazier Lifesciences Acquisition Corporation
(Investment Holding Companies)
Independent Director 2020
Millendo Therapeutics US, Inc. Director 2012
Sharp HealthCare Director -
Sanford Burnham Prebys Medical Discovery Institute Trustee -
Pionyr Immunotherapeutics, Inc. Director 2017
ChromaCode, Inc. Director 2018
Xoc Pharmaceuticals, Inc. Director 2018
Qpex Biopharma, Inc. Director 2018
Trex Bio, Inc. Executive Chairman -
Certara Holding, Inc. Director -
Recludix Pharma, Inc. Director -
NEA Management Co. LLC Venture Partner 2019


Holdings of Carol Giltner Gallagher 
NameEquities%Valuation
Atara Biotherapeutics, Inc. (ATRA)
(Biotechnology & Medical Research)
111,8180.13%2,001,542 USD
Frazier Lifesciences Acquisition Corp.30,0000.87%299,850 USD
Certara, Inc. (CERT)
(Software)
7,0590.0045%233,653 USD
Tempest Therapeutics, Inc. (TPST)
(Biotechnology & Medical Research)
2,1290.032%30,807 USD
Turning Point Therapeutics, Inc. (TPTX)
(Biotechnology & Medical Research)
00.0000%0 USD


Carol Giltner Gallagher: Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
More news


© 2021 People and Ownership :   
Carol Giltner Gallagher : Connections